3GWT
Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID14-4 |
Synchrotron site | ESRF |
Beamline | ID14-4 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2003-11-30 |
Detector | ADSC QUANTUM 4 |
Wavelength(s) | 0.9393 |
Spacegroup name | I 21 21 21 |
Unit cell lengths | 88.706, 94.783, 105.995 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 20.000 - 1.750 |
R-factor | 0.20716 |
Rwork | 0.205 |
R-free | 0.24970 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 3frg |
RMSD bond length | 0.016 |
RMSD bond angle | 1.529 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | REFMAC |
Refinement software | REFMAC |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 24.910 | 1.810 |
High resolution limit [Å] | 1.750 | 1.750 |
Rmerge | 0.060 | 0.589 |
Number of reflections | 45051 | |
<I/σ(I)> | 12.9 | 3.1 |
Completeness [%] | 99.9 | 100 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 277 | 14-18% PEG 3000, 10% Glycerol, 50mM Sodium Cacodylate pH 6.5, 100mM Sodium Acetate, 1M Sodium Chloride, 1% DMF, 5mM DTT , VAPOR DIFFUSION, SITTING DROP, temperature 277K |